Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans.

Eitemau Tebyg

• In vivo complement activation and binding of C3 to encapsulated Cryptococcus neoformans.
  gan: Truelsen, K, et al.
  Cyhoeddwyd: (1992)
• Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.
  gan: Kozel, T R, et al.
  Cyhoeddwyd: (1991)
• Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
  gan: Kozel, T R, et al.
  Cyhoeddwyd: (1989)
• Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
  gan: Kozel, T R
  Cyhoeddwyd: (1983)
• Bivalency Is Required for Anticapsular Monoclonal Antibodies To Optimally Suppress Activation of the Alternative Complement Pathway by the Cryptococcus neoformans Capsule
  gan: Kozel, Thomas R., et al.
  Cyhoeddwyd: (1998)